REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The global oligonucleotide pool library market size was 1072.9 million in 2020. As per our research, the oligonucleotide pool library market is expected to reach USD 1886.9 million by 2027, exhibiting a CAGR of 8.4% during the forecast period. The COVID-19 pandemic has been unprecedented and staggering, oligonucleotide pool library experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.
The chemical synthesis of comparatively tiny segments of nucleic acids with specified chemical structure (sequence) is known as oligonucleotide synthesis. The technology is particularly valuable in modern laboratory practice since it allows for quick and low-cost access to tailored oligonucleotides of the appropriate sequence. It is also beneficial for molecular diagnostics in a variety of disorders, including the identification of infectious diseases such as hepatitis and SARS-COV2, as well as the diagnosis of cancer.
New oligo sequence applications in many domains of biotechnology are expected to drive oligonucleotide pool library market expansion. One of the main developing fields of use for oligonucleotide synthesis is a need of molecular diagnostics within precision medicine.
COVID-19 Impact: Rise in the Health Issues to Advance Market Growth
The COVID-19 pandemic has impacted operations in medical facilities around the world. The sickness has compelled a number of sectors, including various sub-domains of healthcare, to temporarily close their doors. However, there has been a beneficial impact and increase in demand for a variety of healthcare services, particularly oligonucleotide pool library products.
Oligonucleotide pool library products are necessary for the development of test kits, therapies, and vaccinations to combat the new Coronavirus illness. Furthermore, with the rise in coronavirus disease (COVID-19) cases and the need for a viable treatment, fresh types of oligonucleotide therapeutics, comprising mRNA and DNA vaccines, are being developed.
LATEST TRENDS
"PCR Primer Category to Stimulate Market Development "
In 2022, the PCR primers category held the largest market share. Primers constitute the most common type of oligonucleotide utilized in PCR. They are part of complementary sequences to the 5' end of the target sequence and are utilized for sequencing or amplification. Primers are increasingly being used in gene sequencing investigations. Because of their usage in fluorescence detection and target amplification, several primer designs with diverse probe- as well as primer-based detection chemicals have been developed.
SEGMENTATION
-
Request a Free Sample to learn more about this report
- By Type
Based on type; the market is divided into DNA oligos, RNA oligos
DNA oligos is the leading part of the type segment.
- By Application
Based on the application; the market is divided into target capture, CRISPR/Cas9 designs, gene synthesis, library preparation, others
Target capture is the leading part of the application segment.
DRIVING FACTORS
"Investment by Several Business to Aid Market Expansion "
Furthermore, several businesses are making investments in oligonucleotide synthesis that is projected to boost oligonucleotide pool library market share throughout the forecast period. SpeeDx, for example, invested in domestic oligonucleotide manufacture in September 2021 to reduce risk in the supply chain and establish a more crucial sovereign capability for critical diagnostics. Such innovations are projected to expand the use of oligonucleotides in medication development, fueling market growth throughout the forecast period.
"High Throughput Sequencing to Foster Industry Progress "
The introduction of new techniques for gene expression analysis, including as CRISPR as well as high-throughput sequencing, has eased genetic screening and genome editing. Such advancements have been seen to have an impact on the requirement for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of lengthy Oligonucleotides with greater precision and yield to meet the growing demand for custom oligos.
RESTRAINING FACTORS
Difficult Delivery of the Product to Limit the Market Evolution
On the contrary, the complexity connected with therapeutic oligos and the difficult delivery of oligonucleotide medications to specific targets may stymie the oligonucleotide pool library market growth expansion.
REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"Constantly Developing Medical Facilities in Asia Pacific to Support Market Advancement"
Due to constantly developing medical facilities, economic development, and increased government backing and investment, Asia Pacific is predicted to demonstrate the quickest market growth throughout the projection period. Furthermore, an increase in incidence of chronic conditions such as COVID-19, cardiovascular disease, cancer, and others, as well as an expansion in government support and expenditure for improving people's health, stimulates market growth.
Furthermore, key competitors in this expanding region provide a profitable opportunity for the oligonucleotide synthesis market. For example, in 2020, IDT (US) established IDT China as a legitimate corporate entity in China in order to better serve its existing clientele in the region, reach out to new clients, and provide simpler access to its whole array of industry-leading products, such as bespoke RNA and DNA oligos, probes, and assays.
KEY INDUSTRY PLAYERS
"Key Players Focus on Partnerships to Gain a Competitive Advantage"
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
The analyst provides a comprehensive picture of the market through the study, synthesis, and summarization of data from various sources, as well as an examination of important variables such as financial gain, sales prices, competition, and promotions. It identifies the key industry influencers and presents various market facets. The information provided is thorough, reliable, and the result of extensive primary and secondary research. The market report provides a comprehensive competitive landscape as well as an in-depth vendor evaluation methodology and analysis based on both qualitative and quantitative studies to accurately forecast market growth.
The reports cover important advances with in market, as well as inorganic and organic growth strategies. Various companies are concentrating on organic business expansion such as product announcements, product approvals, and other things like patents and events. Acquisitions, partnerships, and collaborations were among the inorganic growth strategies observed in the market. The above activities have paved the way for market participants to expand their business and customer base. With the growing demands for filter products in the international market, market participants in the market are expected to benefit from substantial growth opportunities in the near future.
List of Market Players Profiled
- Agilent (U.S.)
- Eurogentec S.A (U.K.)
- Sigmaaldrich (U.S.)
- Illumnia (U.S.)
- L.G.C Biosearch Technologies (U.S.)
- Eurofins Genomics (Germany)
- Roche NimbleGe (U.S.)
- Integrated DNA Technologies (U.S.)
- Nitto Denko Avecia Inc (U.S.)
- General Biosystems (U.S.)
- MYcroarray (U.K.)
- Twist Bioscience (U.S.)
- CustomArray (U.S.)
- LC Sciences (U.S.)
- Creative Biogene (U.S.)
REPORT COVERAGE
This research offers a thorough analysis of the global market, covering all relevant areas. This includes everything from a broad market overview to micro-level information about size of the market, degree of competition, evolution trend, opportunities in the market, important market drivers, and SWOT opportunities and threats. The reader can use the study to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the situation of the corporate organization.
In a nutshell, this study should be read by all market participants, traders, academics, analysts, business planners, and anyone else with an interest in the market. The market competitive landscape is another area that the report structure focuses on. This report presents in depth information the share of the market, macroeconomic indicators, product scenario, operation circumstances of the major players, which aids readers in the industry in recognizing the key rivals and better understanding the market's competitive landscape.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 1072.9 Million in 2020 |
Market Size Value By |
US$ 1886.9 Million by 2027 |
Growth Rate |
CAGR of 8.4% from 2020 to 2027 |
Forecast Period |
2022-2027 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the oligonucleotide pool library market expected to touch by 2027?
The global oligonucleotide pool library market size is expected to reach USD 1886.9 million by 2027.
-
What CAGR is the oligonucleotide pool library market expected to exhibit by 2027?
The oligonucleotide pool library market is expected to exhibit a CAGR of 8.4% by 2027.
-
Which are the driving factors of the oligonucleotide pool library market?
The driving factors of the oligonucleotide pool library market are investment by several business and high throughput sequencing
-
Which are the key players or most dominating companies functioning in the oligonucleotide pool library market?
Agilent, Eurogentec S.A, Sigmaaldrich, Illumnia, L.G.C Biosearch Technologies are the key players or most dominating companies functioning in the oligonucleotide pool library market.